{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:51:17Z","timestamp":1792637477603,"version":"4.5.0"},"reference-count":44,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The effects of polycystic ovary syndrome (PCOS) on cardiovascular morbidity and mortality are unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This work aims to establish the relative risk of myocardial infarction (MI), stroke, angina, revascularization, and cardiovascular mortality for women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were extracted from the Clinical Practice Research Datalink Aurum database. Patients with PCOS were matched to controls (1:1) by age, body mass index (BMI) category, and primary care practice. The primary outcome was the time to major adverse cardiovascular event (MACE); a composite end point incorporating MI, stroke, angina, revascularization and cardiovascular mortality. Secondary outcomes were the individual MACE end points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 219\u2005034 individuals with a diagnosis of PCOS, 174\u2005660 (79.7%) met the eligibility criteria and were matched. Crude rates of the composite end point, MI, stroke, angina, revascularization, and cardiovascular mortality were respectively 82.7, 22.7, 27.4, 32.8, 10.5, and 6.97 per 100\u2005000 patient-years for cases, and 64.3, 15.9, 25.7, 19.8, 7.13, and 7.75 per 100\u2005000 patient-years for controls. In adjusted Cox proportional hazard models (CPHMs), the hazard ratios (HRs) were 1.26 (95% CI, 1.13-1.41), 1.38 (95% CI, 1.11-1.72), 1.60 (95% CI, 1.32-1.94), and 1.50 (95% CI, 1.08-2.07) for the composite outcome, MI, angina, and revascularization, respectively. In a time-dependent CPHM, weight gain (HR 1.01; 1.00-1.01), prior type 2 diabetes mellitus (T2DM) (HR 2.40; 1.76-3.30), and social deprivation (HR 1.53; 1.11-2.11) increased risk of progression to the composite end point.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The risk of incident MI, angina, and revascularization is increased in young women with PCOS. Weight and T2DM are potentially modifiable risk factors amenable to intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgab392","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T14:05:46Z","timestamp":1622556346000},"page":"e3369-e3380","source":"Crossref","is-referenced-by-count":140,"title":["Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study"],"prefix":"10.1210","volume":"106","author":[{"given":"Thomas R","family":"Berni","sequence":"first","affiliation":[{"name":"Pharmatelligence, Cardiff CF24 3FR, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L","family":"Morgan","sequence":"additional","affiliation":[{"name":"Pharmatelligence, Cardiff CF24 3FR, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1165-9092","authenticated-orcid":false,"given":"D Aled","family":"Rees","sequence":"additional","affiliation":[{"name":"Neuroscience and Mental Health Research Institute, School of Medicine, Cardiff University, Cardiff CF24 4HQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"9","key":"2021120108550374400_CIT0001","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2012-1690","article-title":"Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study","volume":"97","author":"Morgan","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021120108550374400_CIT0002","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2007-2117","article-title":"Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome","volume":"93","author":"Barber","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021120108550374400_CIT0003","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2265.1996.00863.x","article-title":"Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome","volume":"45","author":"Sampson","year":"1996","journal-title":"Clin Endocrinol."},{"issue":"7","key":"2021120108550374400_CIT0004","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"11","key":"2021120108550374400_CIT0005","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"3","key":"2021120108550374400_CIT0006","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2265.2012.04490.x","article-title":"Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies","volume":"78","author":"Sprung","year":"2013","journal-title":"Clin Endocrinol."},{"issue":"11","key":"2021120108550374400_CIT0007","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021120108550374400_CIT0008","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1210\/jc.2005-0011","article-title":"Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease","volume":"90","author":"Meyer","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021120108550374400_CIT0009","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","article-title":"Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health\u2013National Heart, Lung, and Blood Institute sponsored Women\u2019s Ischemia Syndrome Evaluation","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"2021120108550374400_CIT0010","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1210\/jc.2014-4415","article-title":"Withdrawn by author","volume":"100","author":"Shaw","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021120108550374400_CIT0011","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot","year":"2011","journal-title":"Hum Reprod Update."},{"issue":"2","key":"2021120108550374400_CIT0012","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijcard.2014.06.079","article-title":"Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"176","author":"Anderson","year":"2014","journal-title":"Int J Cardiol."},{"issue":"5","key":"2021120108550374400_CIT0013","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/EJE-14-1108","article-title":"Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome","volume":"172","author":"Glintborg","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"9","key":"2021120108550374400_CIT0014","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.18632\/oncotarget.23985","article-title":"Coronary artery disease risk in young women with polycystic ovary syndrome","volume":"9","author":"Ding","year":"2018","journal-title":"Oncotarget."},{"issue":"3","key":"2021120108550374400_CIT0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman\u2019s long-term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021120108550374400_CIT0016","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/cen.12068","article-title":"Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study","volume":"78","author":"Mani","year":"2013","journal-title":"Clin Endocrinol."},{"issue":"9","key":"2021120108550374400_CIT0017","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/jwh.2015.5441","article-title":"Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome","volume":"25","author":"Merz","year":"2016","journal-title":"J Womens Health"},{"issue":"4","key":"2021120108550374400_CIT0018","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2017-02421","article-title":"High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study","volume":"103","author":"Meun","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2021120108550374400_CIT0019","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021120108550374400_CIT0020","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.JIM.0000446834.90599.5d","article-title":"Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population","volume":"62","author":"Sirmans","year":"2014","journal-title":"J Investig Med."},{"issue":"7","key":"2021120108550374400_CIT0021","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol."},{"issue":"5","key":"2021120108550374400_CIT0022","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol."},{"issue":"6","key":"2021120108550374400_CIT0023","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol."},{"issue":"23","key":"2021120108550374400_CIT0024","doi-asserted-by":"crossref","first-page":"33715","DOI":"10.18632\/oncotarget.9553","article-title":"Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget."},{"issue":"5","key":"2021120108550374400_CIT0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"issue":"2","key":"2021120108550374400_CIT0026","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1210\/jc.2017-01958","article-title":"Impaired lipolysis, diminished fat oxidation, and metabolic inflexibility in obese girls with polycystic ovary syndrome","volume":"103","author":"Kim","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021120108550374400_CIT0027","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/er.2007-0006","article-title":"Cardiovascular actions of insulin","volume":"28","author":"Muniyappa","year":"2007","journal-title":"Endocr Rev."},{"issue":"6","key":"2021120108550374400_CIT0028","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cen.12003","article-title":"The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?","volume":"77","author":"Lansdown","year":"2012","journal-title":"Clin Endocrinol."},{"key":"2021120108550374400_CIT0029","doi-asserted-by":"crossref","first-page":"552421","DOI":"10.3389\/fcvm.2020.552421","article-title":"Risk of cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: a meta-analysis of cohort studies","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Cardiovasc Med."},{"issue":"12","key":"2021120108550374400_CIT0030","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/09513590.2017.1347779","article-title":"Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis","volume":"33","author":"Zhou","year":"2017","journal-title":"Gynecol Endocrinol."},{"issue":"1","key":"2021120108550374400_CIT0031","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/09513590.2019.1650337","article-title":"Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"36","author":"Ramezani Tehrani","year":"2020","journal-title":"Gynecol Endocrinol."},{"issue":"6","key":"2021120108550374400_CIT0032","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update."},{"issue":"4","key":"2021120108550374400_CIT0033","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021120108550374400_CIT0034","doi-asserted-by":"crossref","first-page":"e0157360","DOI":"10.1371\/journal.pone.0157360","article-title":"Rheumatoid arthritis disadvantages younger patients for cardiovascular diseases: a meta-analysis","volume":"11","author":"Fransen","year":"2016","journal-title":"PloS One."},{"issue":"1","key":"2021120108550374400_CIT0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol."},{"issue":"6","key":"2021120108550374400_CIT0036","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med."},{"issue":"11","key":"2021120108550374400_CIT0037","doi-asserted-by":"crossref","first-page":"e017184","DOI":"10.1136\/bmjopen-2017-017184","article-title":"Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes","volume":"7","author":"Roberts","year":"2017","journal-title":"BMJ Open."},{"issue":"2","key":"2021120108550374400_CIT0038","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/jc.2015-3543","article-title":"Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study","volume":"101","author":"Ollila","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021120108550374400_CIT0039","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cen.13795","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"89","author":"Teede","year":"2018","journal-title":"Clin Endocrinol."},{"key":"2021120108550374400_CIT0040","volume-title":"Principles and Practice of Screening for Disease","author":"Wilson","year":"1968"},{"issue":"3","key":"2021120108550374400_CIT0041","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2007-2117","article-title":"Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome","volume":"93","author":"Barber","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021120108550374400_CIT0042","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/cen.12986","article-title":"Influence of race\/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study","volume":"85","author":"Chang","year":"2016","journal-title":"Clin Endocrinol."},{"issue":"2","key":"2021120108550374400_CIT0043","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.fertnstert.2013.10.055","article-title":"Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected]","volume":"101","author":"Hillman","year":"2014","journal-title":"Fertil Steril."},{"issue":"5","key":"2021120108550374400_CIT0044","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters","volume":"90","author":"Carmina","year":"2005","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab392\/38826437\/dgab392.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/9\/e3369\/41379386\/dgab392.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/9\/e3369\/41379386\/dgab392.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T08:49:49Z","timestamp":1638348589000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/9\/e3369\/6290890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,6,1]]},"published-print":{"date-parts":[[2021,8,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab392","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,6,1]]}}}